Beova, a new drug introduced by Jeil Pharmaceutical, will be available for Rx at general hospitals. According to related industries, Beova, an overactive bladder treatment, is currently available at 22 medical institutions nationwide, including SMC and AMC, as well as advanced general hospitals, Gangnam Severance Hospital, Sangnam Sacred Heart Hospital, Dongtan Sacred Heart Hospital, Chungnam National University Hospital, and Hanyang University Hospital (headquarters, Guri).
Beova is a new drug introduced by Jeil Pharm from Japan's Kyorin Pharmaceuticals in November 2019. It obtained domestic development, manufacturing, and sales rights, and imported raw materials to produce finished products in domestic fact